("GenSci"), RTW Investments, LP ("RTW"), and Yarrow Bioscience, Inc. ("Yarrow") today announced an exclusive global ex-China license agreement for GS-098, a clinical-stage, first-in-class, humanized ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored drug conjugate technology for cancer and ...

Meat isn't the only protein that aids in weight loss. See plant-based options to help you slim down and provide good nutrition without saturated fat.

BMS signed a multiyear agreement with antibody specialist Harbour BioMed, which has operations in the US, the Netherlands, ...

Anfield Energy Inc. ("Anfield" or the "Company") is pleased to announce that it has signed a definitive stock purchase agreement with Douglas L. Beahm, P.E., P.G., the Chief Operating Officer of the ...

GenSci and RTW Investments announce exclusive global ex-China license agreement for GS-098: Shanghai Thursday, December 18, 2025, 17:00 Hrs [IST] Shanghai Scizeng Medical Technolo ...

Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

As part of the PDAOAI initiative, Oncotelic has curated a comprehensive TGF-β literature corpus comprising more than 125,000 PubMed abstracts, representing the near-totality of scientific knowledge ...

Quantum-Si Incorporated ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation ...

Biotech investors hunting for explosive growth may want to look closely at two emerging innovators making significant progress in high-impact therapeutic areas. Kyverna Therapeutics (KYTX) is ...

Detailed price information for Oncotelic Therapeutics Inc (OTLC) from The Globe and Mail including charting and trades.

Mixed chimerism or relapses following TSC-101 infusions were found to be significantly associated with greater ex vivo expansion of TCR-T cells during the manufacturing process. A new commercial-ready ...